Modified Blalock-Taussig Shunt: A Single-Center Experience and Follow-Up
DOI:
https://doi.org/10.1532/hsf.2715Keywords:
modified Blalock-Taussig shunt, palliation, risk factor, pulmonary arterioplasty, follow-upAbstract
Background: The modified Blalock-Taussig shunt (MBTS) is used to palliate patients with restrictive pulmonary blood flow in complex cardiac anomalies. We describe the immediate and follow-up results of patients with MBTS in our center.
Methods: Patients who received MBTS (excluding those with hypoplastic left heart syndrome) from May 2008 to December 2018 were retrospectively identified. Hospital records were evaluated to determine patient demographics, diagnoses, and perioperative data. Patients were followed up by echocardiograph to evaluate the patency of the graft until stage II procedure or death.
Results: MBTS was performed in 25 patients by 2 surgeons; 16% were neonates, and 60% had pulmonary atresia and 24% tetralogy of Fallot. The patients’ median age was 2.6 months (range 0.2 to 372), and median weight was 5.3 kg (range 1.9 to 45). Preoperative oxygen saturation (SaO2) was 68.7% ± 7.8%. Forty-eight percent of patients received a 3.5-mm graft, and 20% received a concomitant pulmonary arterioplasty with cardiopulmonary bypass. Postoperative SaO2 was 83.2% ± 3.6%, significantly different from preoperative SaO2 (P < .05). Follow-up duration was 1.2 years (range 0.3 to 7.8), with no graft blockage. Three patients died in hospital from cardiorespiratory decompensation after MBTS with concomitant pulmonary arterioplasty. The median age of patients receiving a stage II procedure was 1 year (range 0.4 to 17.4). Actuarial 1-year survival was 79.7% (95% confidence interval 53.1% to 92.2%).
Conclusion: MBTS continues to be valuable for palliation of complicated cyanotic congenital heart disease, yet mortality was considerable with concomitant pulmonary arterioplasty. With effective coagulation, the patency rate of grafts was high.
References
Ahmad U, Fatimi SH, Naqvi I, et al. 2008. Modified Blalock-Taussig shunt: Immediate and short-term follow-up results in neonates. Heart Lung Circ 17:54-58.
Alkhulaifi AM, Lacour-Gayet F, Serraf A, Belli E, Planché C. 2000. Systemic pulmonary shunts in neonates: Early clinical outcome and choice of surgical approach. Ann Thorac Surg 69:1499-1504.
Alsoufi B, Gillespie S, Mori M, Clabby M, Kanter K, Kogon B. 2016. Factors affecting death and progression towards next stage following modified Blalock-Taussig shunt in neonates. Eur J Cardiothorac Surg 50:169-177.
Alsoufi B, Mori M, McCracken C, et al. 2015. Results of primary repair versus shunt palliation in ductal dependent infants with pulmonary atresia and ventricular septal defect. Ann Thorac Surg 100:639-646.
Angeli E, Pace Napoleone C, Balducci A, et al. 2012. Natural and modified history of single-ventricle physiology in adult patients. Eur J Cardiothorac Surg 42:996-1002.
Blalock A, Taussig HB. 1945. The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. JAMA 128:189-202.
Bove EL, Kohman L, Sereika S, et al. 1987. The modified Blalock-Taussig shunt: Analysis of adequacy and duration of palliation. Circulation 76(3 pt 2):III19-III23.
Bove T, Vandekerckhove K, Panzer J, De Groote K, De Wolf D, François K. 2015. Disease-specific outcome analysis of palliation with the modified Blalock-Taussig shunt. World J Pediatr Congenit Heart Surg 6:67-74.
de Leval MR, McKay R, Jones M, Stark J, Macartney FJ. 1981. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. J Thorac Cardiovasc Surg 81:112-119.
Di Donato RM, Jonas RA, Lang P, Rome JJ, Mayer JE Jr., Castaneda AR. 1991. Neonatal repair of tetralogy of Fallot with and without pulmonary atresia. J Thorac Cardiovasc Surg 101:126-137.
Dirks V, Prêtre R, Knirsch W, et al. 2013. Modified Blalock Taussig shunt: A not-so-simple palliative procedure. Eur J Cardiothorac Surg 44:1096-1102.
Elella RA, Umereta N, Alabari I, Al Ahmadi M, Al Wadai A. 2014. The short- and long-term effect of Blalock-Taussig shunt size on the outcome after first palliative surgery for cyanotic heart diseases. Ann Saudi Med 34:494-498.
Gustafson RA, Murray GF, Warden HE, Hill RC, Rozar GE Jr. 1988. Early primary repair of tetralogy of Fallot. Ann Thorac Surg 45:235-241.
Kandakure PR, Dharmapuram AK, Ramadoss N, Babu V, Rao IM, Murthy KS. 2010. Sternotomy approach for modified Blalock-Taussig shunt: Is it a safe option? Asian Cardiovasc Thorac Ann 18:368-372.
McKay R, de Leval MR, Rees P, Taylor JF, Macartney FJ, Stark J. 1980. Postoperative angiographic assessment of modified Blalock-Taussig shunts using expanded polytetrafluoroethylene (Gore-Tex). Ann Thorac Surg 30:137-145.
McKenzie ED, Khan MS, Samayoa AX, et al. 2013. The Blalock-Taussig shunt revisited: A contemporary experience. J Am Coll Surg 216:699-704; discussion 704-706.
Nakashima K, Itatani K, Oka N, et al. 2014. Pulmonary annulus growth after the modified Blalock-Taussig shunt in tetralogy of Fallot. Ann Thorac Surg 98:934-940.
Norwood WI, Lang P, Casteneda AR, Campbell DN. 1981. Experience with operations for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 82:511-519.
Odim J, Portzky M, Zurakowski D, et al. 1995. Sternotomy approach for the modified Blalock-Taussig shunt. Circulation 92:II256-II261.
Petrucci O, O’Brien SM, Jacobs ML, Jacobs JP, Manning PB, Eghtesady P. 2011. Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg 92:642-651; discussion 651-652.
Rao MS, Bhan A, Talwar S, Sharma R. 2000. Modified Blalock-Taussig shunt in neonates: Determinants of immediate outcome. Asian Cardiovasc Thorac Ann 8:339-343.
Sasikumar N, Hermuzi A, Fan CS, et al. 2017. Outcomes of Blalock-Taussig shunts in current era: A single center experience. Congenit Heart Dis 12:808-814.
Singh SP, Chauhan S, Choudhury M, et al. 2014. Modified Blalock Taussig shunt: Comparison between neonates, infants and older children. Ann Card Anaesth 17:191-197.
Şişli E, Tuncer ON, Şenkaya S, et al. 2019. Blalock-Taussig shunt size: Should it be based on body weight or target branch pulmonary artery size? Pediatr Cardiol 40:38-44.
Williams JA, Bansal AK, Kim BJ, et al. 2007. Two thousand Blalock-Taussig shunts: A six-decade experience. Ann Thorac Surg 84:2070-2075; discussion 2070-2075.
